Endometrial Cancer Trial, Recruiting NCT06435663 Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06435663
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with uterine fibroids (located within the muscle wall, or growing on the inside or outside of the uterus, classified as FIGO types 2–6) or adenomyosis (a condition where the uterine lining grows into the muscle of the uterus)
  • People whose imaging scans show either no bowel (intestine) blocking the treatment path, or where that blockage can be cleared to make the treatment safe
  • People whose layer of fat under the skin of the abdomen measures 4 cm or less
  • People where the distance from the skin of the abdomen to the area being treated measures 14 cm or less
  • People who are in generally good health and are able to lie face-down for 2 hours or more
  • Adult women who have not been able to conceive (infertile)

Who may not be able to join:

  • People whose diagnosis is not clearly confirmed
  • People whose fibroids or adenomyosis have grown rapidly in a short period of time, or where scans suggest any possibility of cancer or uncertain malignant potential
  • People who have an active skin infection in the area where treatment would be applied
  • People with an uncontrolled acute pelvic infection
  • People in poor general health, or with serious problems affecting the heart, liver, or kidneys
  • People with severe blood clotting disorders
  • People who have large scars on the lower abdomen in the treatment area
  • People for whom sedative or pain-relief medications cannot safely be used
  • Postmenopausal people whose fibroids or adenomyosis have grown larger after menopause
  • People who are pregnant, or who have a mental health condition, cognitive impairment, or any other condition that would prevent them from cooperating with the treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 0579-89935052

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Treatment effectiveness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov